[ExpireDate]: 2.4.2024
[ExternalReference]: 2024-513473
[FtsReference]: 2024-006880
[FtsS09F02ContractNotice]
[Information]
[FtsS09F02ContractNotice]
[NoticeContract]
[Section1]: [Ca]
I.1)
[NameAddressContact]
University of Exeter
RC000653
Northcote House
Exeter
EX4 4QH
UK
[Contactpoint]:
Megan Brine
[AddressPhone]:
+44 1392723333
[AddressEmail]:
m.brine@exeter.ac.uk
[Nutscode]:
UKK -
SOUTH WEST (ENGLAND)
[UrlGeneral]:
http://www.exeter.ac.uk
[UrlBuyerprofile]:
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042
I.3)
[InfoTendering]
[AddressObtainDocs]:
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=79110&B=EXETER[AddressFurtherinfo]
[AsContactsAbove]:
[AddressSendTendersRequest]
[AddressSendTenders]:
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=79110&B=EXETER
[AddressSendTendersRequest]
[AddressToAbove]
I.4)
[CaType]
[MaintypePublicbody]
I.5)
[Mainactivity]
[MainactivEducation]
[Section2]: [Object]
II.1)
[QuantityScopeContract]
II.1.1)
[TitleContract]
Optical Electromyography Probe
[Fileref]:
UOE/2023/049/MB
II.1.2)
[CpvMain]
38000000
-
II.1.3)
[TypeContract]
[Supplies]
II.1.4)
[DescrShort]
Production of Optical Electromyography probes in accordance with the specifications set out in the University's Invitation to Tender documents.
II.1.5)
[ValueMagnitudeEstimatedTotal]
[ValueExclVat]: 750000.00
GBP
II.1.6)
[LotsInfo]
[DivisionLots]:
[No]
II.2)
[Description]
II.2.2)
[CpvAdditional]
38000000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKK -
SOUTH WEST (ENGLAND)
II.2.4)
[DescrProcurement]
A team of academics and clinicians from the Universities of Exeter and Bristol, Sheffield Teaching Hospitals NHS Foundation Trust, and lead by the University of Sheffield have funding from the Medical Research Council DPFS to develop a device to perform an “optical EMG” to advance the diagnosis of nerve and muscle disorders.
Nerve and muscle diseases (‘neuromuscular diseases’) comprise a heterogeneous group of disorders that can be difficult to diagnose, often requiring multiple tests and several years to arrive at a diagnosis. While many of these conditions are, at present, incurable, there are therapeutics undergoing clinical trials. As a result, biomarkers for the diagnosis and monitoring of neuromuscular diseases are more important than ever.
In this project we propose an ‘optical EMG’, a combination of electromyography, a standard clinical test that records the electrical activity arising from muscle, and optical spectroscopy, a light-based technique that provides additional information on a sample using a laser.
We are seeking to award a contract to a single supplier to produce these medical devices.
Nerve and muscle diseases (‘neuromuscular diseases’) comprise a heterogeneous group of disorders that can be difficult to diagnose, often requiring multiple tests and several years to arrive at a diagnosis. While many of these conditions are, at present, incurable, there are therapeutics undergoing clinical trials. As a result, biomarkers for the diagnosis and monitoring of neuromuscular diseases are more important than ever.
In this project we propose an ‘optical EMG’, a combination of electromyography, a standard clinical test that records the electrical activity arising from muscle, and optical spectroscopy, a light-based technique that provides additional information on a sample using a laser.
We are seeking to award a contract to a single supplier to produce these medical devices.
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 750000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
48
[RenewalsSubject]:
[No]
II.2.9)
[LimitOperators]
[EnvisagedMin]:
1
/
[MaxNumber]:
5
[CriteriaChoosingLimited]:
The University intends to shortlist the top three bidders at Stage 1, who will be invited to Tender at Stage 2. The fourth and fifth ranked suppliers may be invited to Stage 2 at the University’s discretion subject to them achieving a minimum score of 60%.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
[Section3]: [InfoLegal]
III.1)
[ConditionsParticip]
III.1.1)
[SituationPersonalIncl]
[InfoEvaluatingRequir]:
In accordance with the tender documents.
III.1.2)
[EconomicFinancialStanding]
[CriteriaSelectionDocs]
III.1.3)
[TechnicalCapacity]
[CriteriaSelectionDocs]
III.2)
[ConditionsContract]
[Section4]: [Procedure]
IV.1)
[Description]
IV.1.1)
[TypeProcedure]
[ProctypeRestricted]
IV.1.8)
[GpaInfo]
[GpaCovered]
: [Yes]
IV.2)
[InfoAdmin]
IV.2.2)
[LimitReceiptTendersReqPart]
[Date]:
2.4.2024
[Time]:
12:00
IV.2.4)
[LanguagesAllowed]
[Language_EN]
IV.2.6)
[MinTimeMaintain]
[DurationMonths]
: 6
([FromStatedDate])
[Section6]: [InfoComplement]
VI.1)
[RecurrenceInfo]
[RecurrentProcurement]:
[No]
VI.4)
[AppealsProcedure]
VI.4.1)
[AppealsBody]
royal Court of Justice
Strand
London
WC2A 2LL
UK
VI.4.2)
[MediationBody]
VI.4.4)